Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs-Reference-Cited by-同舟云学术

Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs

Published:2024-05-16 Issue:11 Volume:67 Page:8757-8790
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Breidenbach Julian¹,Voget Rabea¹,Si Yaoyao¹,Hingst Alexandra¹,Claff Tobias¹^ORCID,Sylvester Katharina¹,Wolf Valentina¹^ORCID,Krasniqi Vesa¹,Useini Abibe²^ORCID,Sträter Norbert²^ORCID,Ogura Yukino³,Kawaguchi Atsushi³,Müller Christa E.¹^ORCID,Gütschow Michael¹^ORCID

Affiliation:

1. Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany

2. Institute of Bioanalytical Chemistry, Center for Biotechnology and Biomedicine, Leipzig University, Deutscher Platz 5, 04103 Leipzig, Germany

3. Department of Infection Biology, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, 305-8575 Tsukuba, Ibaraki, Japan

Funder

Deutsche Forschungsgemeinschaft

Volkswagen Foundation

Bonn International Graduate School of Drug Sciences

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00053

Reference69 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. A new coronavirus associated with human respiratory disease in China

3. A pneumonia outbreak associated with a new coronavirus of probable bat origin

4. Recent advances in small-molecular therapeutics for COVID-19

5. Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential